Changwei Dou Selected Research

Changwei Dou Research Topics

Disease

23	Neoplasms (Cancer) 01/2023 - 11/2014
19	Hepatocellular Carcinoma (Hepatoma) 08/2023 - 11/2014
11	Neoplasm Metastasis (Metastasis) 01/2023 - 12/2014
3	Hemorrhage 01/2022 - 01/2020
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018 - 02/2015
2	Breast Neoplasms (Breast Cancer) 03/2021 - 12/2016
2	Cholangiocarcinoma 11/2020 - 10/2020
2	Lung Neoplasms (Lung Cancer) 01/2020 - 02/2019
2	Hypoxia (Hypoxemia) 01/2019 - 01/2017
2	Glioma (Gliomas) 11/2018 - 05/2016
1	Klatskin Tumor 05/2023
1	Abdominal Abscess 10/2020
1	Liver Failure 10/2020
1	Wound Infection (Wound Infections) 10/2020
1	Infections 10/2020
1	Gallbladder Neoplasms (Gallbladder Cancer) 01/2020
1	Rhabdoid Tumor (Rhabdoid Tumors) 01/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020
1	Intestinal Neoplasms (Intestinal Cancer) 02/2019
1	Ovarian Neoplasms (Ovarian Cancer) 02/2019
1	Colonic Neoplasms (Colon Cancer) 01/2018
1	Thrombosis (Thrombus) 12/2017
1	Fibrosis (Cirrhosis) 01/2017
1	Carcinogenesis 01/2017
1	Lymphoma (Lymphomas) 12/2016
1	Inflammation (Inflammations) 10/2015
1	Carcinoma (Carcinomatosis) 05/2015
1	Portal Hypertension 02/2015

Drug/Important Bio-Agent (IBA)

6	MicroRNAs (MicroRNA)IBA 01/2019 - 11/2014
5	Proteins (Proteins, Gene)FDA Link 03/2021 - 02/2016
5	Biomarkers (Surrogate Marker)IBA 03/2021 - 12/2014
3	Histone Acetyltransferases (Histone Acetyltransferase)IBA 08/2023 - 05/2016
3	Small Interfering RNA (siRNA)IBA 10/2019 - 02/2015
2	Cyclin D1IBA 01/2023 - 04/2016
2	Oviductus RanaeIBA 01/2023 - 11/2018
2	Protein Hydrolysates FDA Link 01/2023 - 11/2018
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 09/2022 - 03/2018
2	Transcription Factors (Transcription Factor)IBA 10/2019 - 05/2016
2	p300-CBP-associated factorIBA 01/2018 - 05/2016
2	Long Noncoding RNAIBA 01/2017 - 08/2016
2	Messenger RNA (mRNA)IBA 01/2017 - 04/2016
2	HMGB1 Protein (HMG1)IBA 06/2016 - 10/2015
2	Indicators and Reagents (Reagents)IBA 06/2016 - 05/2015
1	6-propylchromone-2-carboxylic acid (PCCA)IBA 05/2023
1	hydroxide ionIBA 10/2020
1	TenascinIBA 10/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2019
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 10/2019
1	Smad Proteins (Mothers Against Decapentaplegic Homolog)IBA 10/2019
1	Connective Tissue Growth FactorIBA 10/2019
1	PeriostinIBA 10/2019
1	platelet-derived growth factor C (PDGF-C)IBA 10/2019
1	Glycine Hydroxymethyltransferase (Serine Hydroxymethyltransferase)IBA 02/2019
1	Fluorouracil (Carac)FDA LinkGeneric 01/2019
1	ChromatinIBA 01/2019
1	Carrier Proteins (Binding Protein)IBA 01/2018
1	Serine (L-Serine)FDA Link 01/2018
1	Conditioned Culture MediaIBA 01/2018
1	Pyruvate KinaseIBA 12/2017
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 12/2017
1	Phosphoglycerate Kinase (Kinase, Phosphoglycerate)IBA 11/2017
1	SirtuinsIBA 11/2017
1	tyrosine receptor (receptor, tyrosine)IBA 01/2017
1	NADPH Oxidase 4IBA 01/2017
1	EnzymesIBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	NADP (NADPH)IBA 01/2017
1	sphingosine kinaseIBA 01/2017
1	Dynamin IIIBA 01/2017
1	lymphocyte-specific protein p50IBA 12/2016
1	Untranslated RNA (Noncoding RNA)IBA 05/2016
1	B-Cell Lymphoma 3 ProteinIBA 04/2016
1	Cadherins (E-Cadherin)IBA 02/2016
1	Tissue Inhibitor of Metalloproteinase-1IBA 05/2015
1	C-terminal binding proteinIBA 02/2015
1	Co-Repressor ProteinsIBA 02/2015
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 12/2014
1	PPAR gammaIBA 11/2014

Therapy/Procedure

3	Length of Stay 01/2022 - 01/2020
2	Lymph Node Excision (Lymph Node Dissection) 11/2020 - 10/2020
1	Hepatectomy 10/2020
1	Laparotomy 01/2020
1	Drug Therapy (Chemotherapy) 01/2019
1	Subcutaneous Injections 01/2018
1	Intraperitoneal Injections 01/2018
1	Splenectomy 02/2015